MNTR Mentor Capital Inc (QB)

Mentor Capital, Inc. (OTC Markets: MNTR) announced that it
has initiated investment in the Medical Marijuana market.  ?The ?munchies? are a godsend to cancer
sufferers who just stop eating food that tastes like wood and leaves them
nauseous,? explains Mentor CEO, Chester Billingsley. ?In the days of clans and
caves, elders with cancer that stopped eating improved the chances of their
grandchildren surviving the lean times. 
That former evolutionary advantage now weakens cancer patients and
decreases their ability to handle chemo and other therapies that today may save
them.? 

Twenty states have already legalized medical marijuana.
However, the key development that cleared the way for Mentor Capital, Inc. to
direct funds toward cannabis in medicine was the August 29, 2013 announcement
by the Justice Department that it won?t challenge state laws that legalize
marijuana.

?Yesterday, I talked to a mother whose 6?4? son had dwindled
to 120 lbs.  We have the medical
knowledge and financial ability to help here and ethically lead the sector forward,
so we must,? concludes Billingsley.

About Mentor Capital:  By acquisition or stock purchase, Mentor
Capital, Inc. seeks to invest in leading companies, including public and
private medical marijuana companies, which improve or reduce the cost of
medical treatments, especially in the fight against cancer. Additional
important information is presented at:  www.MentorCapital.com

Forward Looking Statements, Safe Harbor and Risk
Descriptions are Incorporated by Reference from the MNTR Company Web Site
above.

For further information contact:

Chester Billingsley, CEO                   

Mentor Capital, Inc.

(760) 788 - 4700 

Mentor Capital (QB) (USOTC:MNTR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Mentor Capital (QB) (USOTC:MNTR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024